JP2015526385A - てんかんの治療のための組成物及び方法 - Google Patents
てんかんの治療のための組成物及び方法 Download PDFInfo
- Publication number
- JP2015526385A JP2015526385A JP2015510893A JP2015510893A JP2015526385A JP 2015526385 A JP2015526385 A JP 2015526385A JP 2015510893 A JP2015510893 A JP 2015510893A JP 2015510893 A JP2015510893 A JP 2015510893A JP 2015526385 A JP2015526385 A JP 2015526385A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- disorder
- administration
- formula
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1791/CHE/2012 | 2012-05-08 | ||
IN1791CH2012 | 2012-05-08 | ||
PCT/IB2013/050740 WO2013167986A2 (fr) | 2012-05-08 | 2013-01-29 | Compositions et méthodes de traitement de l'épilepsie |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2015526385A true JP2015526385A (ja) | 2015-09-10 |
Family
ID=54187089
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015510893A Pending JP2015526385A (ja) | 2012-05-08 | 2013-01-29 | てんかんの治療のための組成物及び方法 |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP2846795A2 (fr) |
JP (1) | JP2015526385A (fr) |
AU (1) | AU2013257707A1 (fr) |
CA (1) | CA2873016A1 (fr) |
SG (1) | SG11201407309XA (fr) |
WO (1) | WO2013167986A2 (fr) |
ZA (1) | ZA201408058B (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015519334A (ja) * | 2012-05-07 | 2015-07-09 | セリックスビオ プライヴェート リミテッド | 抗血小板薬のプロドラッグ |
JP2015527309A (ja) * | 2012-07-03 | 2015-09-17 | セリックスビオ プライヴェート リミテッド | 中等度から重度の疼痛の治療のための組成物及び方法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20170048313A (ko) * | 2014-06-02 | 2017-05-08 | 케토젠 인코포레이티드 | 발작 및 기타 중추신경계 장애 및 병증 치료용 화합물 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ292256B6 (cs) * | 1995-05-05 | 2003-08-13 | Novo Nordisk A/S | Farmaceutická směs a způsob její přípravy |
WO2006062980A2 (fr) * | 2004-12-07 | 2006-06-15 | Nektar Therapeutics | Formulation non cristalline stable comprenant de la tiagabine |
US8338621B2 (en) * | 2005-12-21 | 2012-12-25 | Ucb S.A. | Process for the preparation of 2-oxo-1-pyrrolidine derivatives |
US8785661B2 (en) * | 2009-05-13 | 2014-07-22 | Nektar Therapeutics | Oligome-containing pyrrolidine compounds |
-
2013
- 2013-01-29 WO PCT/IB2013/050740 patent/WO2013167986A2/fr active Application Filing
- 2013-01-29 CA CA2873016A patent/CA2873016A1/fr not_active Abandoned
- 2013-01-29 SG SG11201407309XA patent/SG11201407309XA/en unknown
- 2013-01-29 JP JP2015510893A patent/JP2015526385A/ja active Pending
- 2013-01-29 AU AU2013257707A patent/AU2013257707A1/en not_active Abandoned
- 2013-01-29 EP EP13787779.1A patent/EP2846795A2/fr not_active Withdrawn
-
2014
- 2014-11-04 ZA ZA2014/08058A patent/ZA201408058B/en unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015519334A (ja) * | 2012-05-07 | 2015-07-09 | セリックスビオ プライヴェート リミテッド | 抗血小板薬のプロドラッグ |
JP2015527309A (ja) * | 2012-07-03 | 2015-09-17 | セリックスビオ プライヴェート リミテッド | 中等度から重度の疼痛の治療のための組成物及び方法 |
Also Published As
Publication number | Publication date |
---|---|
WO2013167986A2 (fr) | 2013-11-14 |
CA2873016A1 (fr) | 2013-11-14 |
ZA201408058B (en) | 2016-03-30 |
AU2013257707A1 (en) | 2014-11-27 |
SG11201407309XA (en) | 2014-12-30 |
EP2846795A2 (fr) | 2015-03-18 |
WO2013167986A3 (fr) | 2015-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6202287B2 (ja) | 炎症性腸疾患の治療のための組成物及び方法 | |
JP6698643B2 (ja) | 多発性硬化症の治療のための組成物及び方法 | |
JP2015518855A5 (fr) | ||
JP2015518855A (ja) | 粘膜炎の治療のための組成物および方法 | |
JP2015520748A (ja) | 炭酸脱水酵素活性の抑制のための組成物及び方法 | |
WO2014115098A1 (fr) | Compositions et procédés pour le traitement de maladies neurologiques et d'une inflammation | |
JP2016508956A (ja) | 局所疼痛の治療のための組成物と治療法 | |
WO2014068463A2 (fr) | Compositions et procédés de traitement d'une inflammation et de troubles métaboliques | |
WO2014091384A2 (fr) | Compositions et méthodes pour le traitement de la mucosite | |
JP2015518854A5 (fr) | ||
JP2015518854A (ja) | 多発性硬化症の治療のための組成物および方法 | |
JP2015526385A (ja) | てんかんの治療のための組成物及び方法 | |
JP2015527309A (ja) | 中等度から重度の疼痛の治療のための組成物及び方法 | |
US9738631B2 (en) | Compositions and methods for the treatment of neurological disorders | |
JP2015519333A5 (fr) | ||
JP2015533114A (ja) | 神経疾患の治療のための組成物及び方法 | |
RU2751770C2 (ru) | Композиции и способы лечения синдрома раздраженного кишечника | |
RU2749188C2 (ru) | Композиции и способы лечения желудочно-кишечных полипов | |
JP2015519334A5 (fr) | ||
WO2013167984A2 (fr) | Compositions et méthodes de traitement de la douleur musculaire | |
JP2015519334A (ja) | 抗血小板薬のプロドラッグ | |
WO2014057439A2 (fr) | Compositions et procédés de traitement de maladies neurologiques et des complications associées | |
US20150087670A1 (en) | Compositions and methods for the treatment of respiratory disorders | |
JP2015529218A (ja) | 炎症と脂質障害の治療のための組成物及び方法 | |
US9290486B1 (en) | Compositions and methods for the treatment of epilepsy |